Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions.
Rodis
Dionisis G
DG
Liatsos
George D
GD
Moulakakis
Antonios
A
Pirounaki
Maria
M
Tasidou
Anna
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001928:Brain Diseases, Metabolic / Q000175:diagnosis; D002524:Cerebellar Ataxia / Q000209:etiology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003951:Diagnostic Errors; D004317:Doxorubicin / Q000008:administration & dosage; D004401:Dysarthria / Q000209:etiology; D017809:Fatal Outcome; D005334:Fever / Q000209:etiology; D006801:Humans; D007057:Ichthyosis / Q000209:etiology*; D008198:Lymph Nodes / Q000473:pathology; D054446:Lymphoma, Primary Cutaneous Anaplastic Large Cell / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis; D020362:Paraneoplastic Cerebellar Degeneration / Q000175:diagnosis* / Q000209:etiology; D010257:Paraneoplastic Syndromes / Q000209:etiology*; D011239:Prednisolone / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone